5 quarters tracked · Beat rate 100% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.10 | $2.37 | +12.8% | Beat |
| Q1 2026 | 2026-03-31 | $1.69 | $2.13 | +25.8% | Beat |
| Q4 2025 | 2025-12-31 | $1.85 | $2.04 | +10.2% | Beat |
| Q3 2025 | 2025-09-30 | $1.70 | $1.96 | +15.4% | Beat |
| Q2 2025 | 2025-06-30 | $1.52 | $1.84 | +20.7% | Beat |
Earnings Beat Rate
West Pharmaceutical Services has beaten analyst EPS estimates in 5 of 5 tracked quarters (100% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →